2019 annual financial data
Aptevo Therapeutics 2019 Net margin
Direct answer
Net margin was -137.85%.
Operating income was -40,962,000 USD and net income was -44,698,000 USD.
Operating cash flow was -42,383,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 32,424,000 USD
- Operating income
- -40,962,000 USD
- Net income
- -44,698,000 USD
- Operating cash flow
- -42,383,000 USD